Fundraising FoxOnc
San Carlos, US · Founded 2020 · 5 known investors
Find your way into Onc
Sign up to see every warm intro you have to Onc
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Onc team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Onc.AI develops the Onclara platform, which uses oncology real-world data to build predictive and prognostic AI models for cancer decision-making. Its products serve pharma companies with Phase IB/II clinical trial decisions and predict immunotherapy response and outcomes for metastatic lung cancer patients.
Founders & leadership
Onc was founded in 2020 by Akshay Nanduri.
Investors · 5
How we know: LifeX Ventures's portfolio page · Not right? Tell us
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
Funding
SEC filings, press & company announcements$6M disclosed across 1 of 2 rounds · 2018–2020
- Undisclosed amountSeries BSep 2018Source ↗
▶$6MraisedDec 2020 · 26 investors · Other TechnologyRule 506(b)
- Salmaan AhmedExecutive Officer
- Jonathan FlemingDirector
- Akshay NanduriExecutive Officer, Director
- Offering amount
- $6M
- Amount sold
- $6M
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Onc do?
- Onc.AI develops the Onclara platform, which uses oncology real-world data to build predictive and prognostic AI models for cancer decision-making. Its products serve pharma companies with Phase IB/II clinical trial decisions and predict immunotherapy response and outcomes for metastatic lung cancer patients.
- Who founded Onc?
- Onc was founded by Akshay Nanduri in 2020.
- Who are Onc's investors?
- Onc's investors include 515 Ventures, LifeX Ventures, Blue Venture Funds, Digitalis Ventures, KdT Ventures.
- How much funding has Onc raised?
- Onc has disclosed $6M raised across 1 of its 2 known rounds.
- Where is Onc headquartered?
- Onc is headquartered in San Carlos, US.